CEO Advice: How to Select the RIGHT Interim CFO
By

FLG Partners is a leading solution for CEOs, boards and management teams when it comes to sourcing experienced interim CFO talent. Whether your company is a small, publicly traded biotech preparing to raise its next equity financing or a large multi-national firm in need of restructuring, margin improvement and cash…Read More

Read More
Raising Capital in Life Sciences in 2022-2023: What Works?
By

Raising money in the capital markets for a biopharma or life sciences company over the last few years has been quite a roller coaster ride. Funding among U.S. biotech startups reached a record high of $77 billion in 2021 (Crunchbase), as investors were attracted to expanding opportunities in genetics, therapeutics…Read More

Read More
5 Lessons in Cash Management from a CFO
By

When I joined FLG in 2020, I brought 20+ years of experience as a finance executive and CFO to the firm. My current focus is technology businesses, including B2B Software and Consumer platforms as well as Healthcare and Life Sciences. I help teams drive strategies as they plan for growth,…Read More

Read More
Equity vs. Debt Financing: Updated for 2022 Market Conditions
By

The Covid-19 pandemic of the past two years, spiking inflation, and supply chain disruptions have created an economic situation that is putting increasing pressure on companies.  Many CFOs have never experienced rising interest rates, high inflation, or recession, all at the same time.  But those of us who have (myself…Read More

Read More

More Posts